| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/19/2009 | CA2698693A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698691A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698682A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698666A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698645A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 03/19/2009 | CA2698400A1 Method and composition for cancer diagnosis and treatment |
| 03/19/2009 | CA2697682A1 Annelated pyridazines for the treatment of tumors driven by inapropriate hedgehog signalling |
| 03/19/2009 | CA2693852A1 Humanized anti-fgf19 antagonists and methods using same |
| 03/19/2009 | CA2693310A1 Lox and loxl2 inhibitors antibodies and uses thereof |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036916A1 Composition for promoting the production of equol |
| 03/18/2009 | EP2036903A1 Potentiator of radiation therapy |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036894A1 Aurora inhibitor |
| 03/18/2009 | EP2036893A1 Abl KINASE INHIBITOR |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036573A1 HLA binding peptides and their uses |
| 03/18/2009 | EP2036561A1 Agent for overcoming resistance to anti-cancer agent |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036557A1 Antitumor agent for thyroid cancer |
| 03/18/2009 | EP2036556A1 Piperidone derivatives and medical uses thereof |
| 03/18/2009 | EP2036550A1 Drug, drug induction device, magnetic detector and method of designing drug |
| 03/18/2009 | EP2035575A2 Methods of treatment |
| 03/18/2009 | EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells |
| 03/18/2009 | EP2035488A1 Micelles for drug delivery |
| 03/18/2009 | EP2035435A1 Novel lapachone compounds and methods of use thereof |
| 03/18/2009 | EP2035434A1 Quinoline derivatives, their preparation, their use, and medicaments comprising them |
| 03/18/2009 | EP2035433A1 Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them |
| 03/18/2009 | EP2035431A1 Pharmaceutical compounds |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP2035426A1 Pyrazolopyrimidones |
| 03/18/2009 | EP2035416A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 03/18/2009 | EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor |
| 03/18/2009 | EP2035396A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2035391A1 Indazole derivatives for treating hsp90-induced diseases |
| 03/18/2009 | EP2035387A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 03/18/2009 | EP2035385A2 Inhibitors of akt (protein kinase b) |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2035360A1 Ship 1 modulator compounds |
| 03/18/2009 | EP2035041A2 Conjugates for innate immunotherapy of cancer |
| 03/18/2009 | EP2035025A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 03/18/2009 | EP2034981A1 Diamidine inhibitors of tdp1 |
| 03/18/2009 | EP2034957A2 Pharmaceutical composition for oral administration |
| 03/18/2009 | EP2034835A2 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone |
| 03/18/2009 | EP2034816A1 O-glycans in the treatment of inflammatory bowel disease and cancers |
| 03/18/2009 | EP1782802B1 Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments |
| 03/18/2009 | EP1768945B1 Substituted hydroxyacetophenon derivatives |
| 03/18/2009 | EP1658289B1 3-substituted imidazopyridine-derivatives as c-kit inhibitors |
| 03/18/2009 | EP1615921B1 Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 03/18/2009 | EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/18/2009 | EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1146789B1 Treating cancers associated with overexpression of her-2/neu |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389756A Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 03/18/2009 | CN101389658A Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 03/18/2009 | CN101389630A Protein kinase inhibitors |
| 03/18/2009 | CN101389629A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389628A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389626A Fused ring heterocycle kinase modulators |
| 03/18/2009 | CN101389622A Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389345A Combinatorial methods and compositions for treatment of melanoma. |
| 03/18/2009 | CN101389343A Doxorubicin formulations for anti-cancer use |
| 03/18/2009 | CN101389337A Rapamycin derivatives for treating neuroblastoma |
| 03/18/2009 | CN101389316A Controlled release solid preparation |
| 03/18/2009 | CN101386869A Human methyl guanine methyl transferase gene eucaryon expression plasmid and construction method and application thereof |
| 03/18/2009 | CN101386818A Extract of sea fungal culture and preparation method and application thereof |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386644A Pumpkin protein 2 and preparation method and application thereof |
| 03/18/2009 | CN101386629A Water-soluble Pt(II) anticancer complexes using 3-acetoxy-1,1-cyclobutane dicarboxylic acid radical as leaving group |
| 03/18/2009 | CN101386625A Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer |
| 03/18/2009 | CN101386624A Vinflunine arginine ester and preparation method thereof and thereof application in preparing medicament for targeted therapy solid tumors and cancer |
| 03/18/2009 | CN101386612A Compounds with 3-phenyl-7-hydroxyl tonka bean camphor structure and medicinal use thereof |
| 03/18/2009 | CN101386607A Taxane derivatives, preparation method and applications thereof |
| 03/18/2009 | CN101386596A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/18/2009 | CN101385860A Camptothecine and non-linear polyethyleneglycol prodrug of derivative thereof |
| 03/18/2009 | CN101385857A Novel nano preparation with stable protein and preparation method and use thereof |
| 03/18/2009 | CN101385850A Treatment of cellular proliferative disorders |
| 03/18/2009 | CN101385843A Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| 03/18/2009 | CN101385788A Chinese herbal medicine preparation for treating ascitic type liver cancer |
| 03/18/2009 | CN101385749A Use of heaven tree extract in preparing antineoplastic medicine |
| 03/18/2009 | CN101385742A CD4+CD25+regulatory T cells from human blood |
| 03/18/2009 | CN101385727A Thiazone and inorganic acid composition for treating malignant entity tumor, preparation method and uses thereof |
| 03/18/2009 | CN101385712A Mouth spray for preventing and treating nausea and emesis after tumor chemotherapy and radiotheraphy and preparation method thereof |
| 03/18/2009 | CN101385711A Anticancer composition loaded with melphalan and lomustine |
| 03/18/2009 | CN101385710A Anticancer composition loaded with cyclophosphamide and carmustine |
| 03/18/2009 | CN101385709A Sustained-released injection containing carmustine of nitrosourea medicine |
| 03/18/2009 | CN101385708A Anti-cancer sustained-released agent containing fotemustine of nitrosourea medicine |
| 03/18/2009 | CN101385707A Anticancer composition loaded with melphalan and carmustine |
| 03/18/2009 | CN101385706A Anticancer composition loaded with melphalan and fotemustine |
| 03/18/2009 | CN101385705A Preparation method of aqueouse solution agent of minoplatin and other platinum complexes |
| 03/18/2009 | CN101385701A Anticancer composition loaded with norcantharidin and galamustine |
| 03/18/2009 | CN101385700A Anticancer composition loaded with 4H-peroxycyclophosphamide and nimustine |
| 03/18/2009 | CN101385699A Sustained-released injection containing nitrosourea medicine |
| 03/18/2009 | CN101385698A Anti-cancer sustained-released implantation agent |
| 03/18/2009 | CN101385696A Sodium alginate microspheres blood vessel suppository containing etoposide and preparation method and uses thereof |